Medicare Enrolled

Dr. Alvin Payne, M.D.

Optician · Texarkana, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1002 TEXAS BLVD, Texarkana, TX 75501
9037943701
In practice since 2005 (20 years)
NPI: 1427056894 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Payne from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Payne? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Payne

Dr. Alvin Payne is an optician in Texarkana, TX, with 20 years in practice. Based on federal Medicare data, Dr. Payne performed 3,760 Medicare services across 2,621 unique beneficiaries.

Between the years covered by Open Payments, Dr. Payne received a total of $4,110 from 35 pharmaceutical and/or device companies across 275 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Payne is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 18% volume in TX$ $4,110 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,760
Medicare services
Top 18% in TX for optician
2,621
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~188 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)606$57$93
Office visit, established patient (30-39 min)520$82$149
Blood draw (venipuncture)515$8$10
Comprehensive metabolic blood panel300$10$85
Complete blood count (CBC) with differential268$8$26
Annual wellness visit, follow-up233$125$130
Automated urinalysis228$2$14
Lipid panel (cholesterol and triglycerides)199$13$52
Hemoglobin A1c test (diabetes monitoring)193$10$38
Flu vaccine, quadrivalent100$69$70
Flu vaccine administration100$29$30
Urine microalbumin test (kidney screening)99$6$63
Office visit, established patient, complex (40-54 min)85$102$210
Office visit, established patient (10-19 min)75$36$59
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous49$18$25
Basic metabolic blood panel40$8$65
Administration of vaccine38$11$30
Prothrombin time test (blood clotting)37$4$18
Electrocardiogram (EKG), 12-lead27$9$52
Red blood cell sedimentation rate, to detect inflammation, non-automated16$4$18
Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use16$282$300
Pneumonia vaccine administration16$29$30
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,110
Total received (2018-2024)
Avg $587/year across 7 years
Top 30% in TX for optician
35
Companies
275
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,110 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$379
2023
$305
2022
$465
2021
$1,018
2020
$869
2019
$452
2018
$621

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$553
Lilly USA, LLC
$416
AstraZeneca Pharmaceuticals LP
$411
Boehringer Ingelheim Pharmaceuticals, Inc.
$359
SANOFI-AVENTIS U.S. LLC
$328
Novo Nordisk Inc
$309
Abbott Laboratories
$166
PFIZER INC.
$153
Janssen Pharmaceuticals, Inc
$153
AbbVie Inc.
$136
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$134
Amgen Inc.
$113
Allergan, Inc.
$96
Novartis Pharmaceuticals Corporation
$89
Esperion Therapeutics, Inc.
$79
Merck Sharp & Dohme Corporation
$79
Medtronic, Inc.
$64
Mannkind Corporation
$59
Paratek Pharmaceuticals, Inc.
$56
Bayer HealthCare Pharmaceuticals Inc.
$55
Kowa Pharmaceuticals America, Inc.
$41
Allergan Inc.
$37
iRhythm Technologies, Inc.
$29
Mylan Specialty L.P.
$22
ABBVIE INC.
$22
Merck Sharp & Dohme LLC
$19
Astellas Pharma US Inc
$16
Phathom Pharmaceuticals, Inc.
$16
NOVARTIS PHARMACEUTICALS CORPORATION
$16
Eisai Inc.
$16
Medtronic MiniMed, Inc.
$15
Xeris Pharmaceuticals, Inc.
$15
ARBOR PHARMACEUTICALS, INC.
$15
Horizon Therapeutics plc
$13
Bardy Diagnostics, Inc.
$11
Top 3 companies account for 33.6% of total payments
Associated products mentioned in payments ›
AFREZZA · AIMOVIG · ANORO · ANORO ELLIPTA · Aimovig · BASAGLAR · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · CHANTIX · Carnation Ambulatory Monitor · DIFICID · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GVOKE HYPOPEN · Guardian Connect · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LYRICA · Leqembi · Livalo · MYRBETRIQ · Minimed 670G System · NEXLETOL · NUZYRA · OFEV · Ozempic · PRALUENT · PREMARIN · PREVNAR 20 · QULIPTA · RAYOS · RELISTOR ORAL · RYBELSUS · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · SYNJARDY · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · Victoza · XARELTO · XIFAXAN · XIFAXANIBSD · Yupelri · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $109 per 100 Medicare services performed
Looking for a optician in Texarkana?
Compare opticians in the Texarkana area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
28
Per 100K population
30.3
County median income
$59,295
Nearest hospital
WADLEY REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Payne is a clinical cardiology specialist, with above-average Medicare volume (top 18% in TX), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Payne experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Payne performed 606 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Payne receive payments from pharmaceutical companies?
Yes. Dr. Payne received a total of $4,110 from 35 companies across 275 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Payne's costs compare to other opticians in Texarkana?
Dr. Payne's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Payne) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →